There were 1,980 press releases posted in the last 24 hours and 443,083 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Published Results from Clinical Trials Demonstrate Therapeutic Potential for Immunomedics’ Sacituzumab Govitecan (IMMU-132) in the Treatment of Metastatic Solid Cancers

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image